Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.7K citations

5-Year Analysis, Neuro-oncology, Oncology +8

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.1K citations · Full text

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.3K citations

Genome Instability, Radiation Therapy, Medicine +12

Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype

Daniel A. Lim, Soonmee Cha, Mary Catherine Mayo et al. · Neuro-Oncology · 2007 · 432 citations · Full text

Pediatric Brain Tumors, Neural Stem Cell, Cerebral Organoid +29

Diagnostic Accuracy of ¹¹C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy

Yuzo Terakawa, Naohiro Tsuyuguchi, Yoshiyasu Iwai et al. · Journal of Nuclear Medicine · 2008 · 416 citations · Full text